Viewing Study NCT00288561


Ignite Creation Date: 2025-12-24 @ 12:58 PM
Ignite Modification Date: 2026-01-28 @ 5:16 AM
Study NCT ID: NCT00288561
Status: COMPLETED
Last Update Posted: 2008-06-19
First Post: 2006-02-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Ranibizumab Administered in Conjunction With Photodynamic Therapy With Verteporfin in Patients With Subfoveal Choroidal Neovascularization and Age-Related Macular Degeneration
Sponsor: Novartis
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CRFB002B2201
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: External Affairs
Old Organization: Novartis

Collaborators